Originally derived from gastric proteins, BPC-157 works systemically to promote blood flow, tissue repair, and cellular regenerationmaking it highly valuable for patients dealing with injuries, chronic inflammation, gastrointestinal dysfunction, or delayed recovery
OASIS 4 also found that oral Wegovy significantly outperformed placebo, cutting an average of 13.6% of participants weight, as opposed to 2.4% in the control group
Choose Surgery If
References Ferrari G, Cook BD, Terushkin V, Pintucci G, Mignatti P
Subsequent studies also examining data from the FDA Adverse Event Reporting System (FDA AERS) reported an increase in reporting rates of PDAC cases in GLP-1RA users over a broader study period 33,34